Detection of the Prevalence of HBV/HCV Coinfection in Anti-HCV-Positive Samples

Creative Commons License

FİDAN I., Cuhadar T., Koc Z., KARAKUŞ R.

KLIMIK JOURNAL, cilt.31, sa.1, ss.16-19, 2018 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5152/kd.2018.06
  • Dergi Adı: KLIMIK JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.16-19
  • Anahtar Kelimeler: Hepatitis C antibodies, hepatitis B surface antigen, co-infection, HEPATITIS-B-VIRUS, COMBINATION THERAPY, REACTIVATION, INFECTION, PATIENT, HBV, EPIDEMIOLOGY, DACLATASVIR, ASUNAPREVIR, FEATURES
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: Chronic hepatitis is a common cause of liver-related morbidity due to hepatotropic viruses, such as hepatitis B virus (HBV) and hepatitis C virus (HCV). HBV/HCV co-infection leads to more severe liver diseases and increased risk of hepatocellular carcinoma. In addition, hepatitis B virus reactivation has been reported after treatment for chronic hepatitis C in patients with HBV/HCV co-infection. In our study, we aimed to detect the prevalence of HBV/HCV co-infection in anti-HCV-positive samples, retrospectively.